Skip to content
FrontierPicks

Dormant

ALM · Almonty Industries Inc.

Last analysed ·

Current thesis

Non-China tungsten narrative moving to an operating footing: Sangdong began throughput 2026-07-01, Q2 revenue rose 498% to C$43.0M on European APT at US$3,075/MTU, and the board authorized a US$300M buyback on 2026-08-17. The shares still sit 23% under the $23.42 high, leaving a maturing narrative — well known, flow thinned since the 2026-08-11 revenue miss — with no company-dated catalyst inside 30 days.

Kill line

A weekly close below $15.50 ends the post-buyback advance and returns the shares into the pre-Q2-print range; secondarily, European APT slipping under US$2,000/MTU, or a Q3 print (~2026-11-12, est.) with a second consecutive revenue miss and adjusted EBITDA not expanding from C$17.6M.

Pick status

Open commitment scored if the kill line above fires How this is scored →

Latest analysis and events for ALM —

As of 29 August 2026, the latest FrontierPicks analysis for Almonty Industries Inc. (ALM): Non-China tungsten narrative moving to an operating footing: Sangdong began throughput 2026-07-01, Q2 revenue rose 498% to C$43.0M on European APT at US$3,075/MTU, and the board authorized a US$300M buyback on 2026-08-17. The shares still sit 23% under the $23.42 high, leaving a maturing narrative — well known, flow thinned since the 2026-08-11 revenue miss — with no company-dated catalyst inside 30 days.

Kill line: A weekly close below $15.50 ends the post-buyback advance and returns the shares into the pre-Q2-print range; secondarily, European APT slipping under US$2,000/MTU, or a Q3 print (~2026-11-12, est.) with a second consecutive revenue miss and adjusted EBITDA not expanding from C$17.6M.

Current Thesis

The leg on offer is the non-China tungsten supply chain moving from promise to production. Sangdong's processing plant in Gangwon Province began throughput on 2026-07-01, and the first quarter that captured any of it — Q2 FY26, reported 2026-08-11 — showed revenue of C$43.0M, up 498% year-over-year and 69% sequentially, with income from mining operations of C$26.1M and adjusted EBITDA of C$17.6M. Behind it sits a price shock: European APT averaged US$3,075/MTU in Q2 2026 against US$453/MTU in Q2 2025.

The complication is that the tape has not rewarded it. The 2026-08-28 close of $18.04 sits 23.0% under the 52-week high of $23.42, with a three-month price change of -5.3%, even after the 2026-08-17 buyback authorization. The narrative is maturing — the Western-tungsten story is well enough known that a 498%-revenue quarter, an offtake repricing worth roughly US$800M and a US$300M repurchase program have not carried the shares back to the high, and the flow behind it has thinned since the 2026-08-11 print missed on the revenue line.

Bullish and bearish views on Almonty Industries Inc.

The model's bull view on Almonty Industries Inc. (ALM), in brief: That converts a spot-price story into a contracted one. The bear view: The revenue line missed. Against US-dollar consensus, Q2 sales of US$31.053M came in under the US$35.038M estimate (Benzinga, 2026-08-11). Revenue grew nearly fivefold and still fell short — the ramp is running behind what the street modelled. The headline EPS beat was almost… Both cases follow in full.

Bull Case

  • That converts a spot-price story into a contracted one.
  • The issuer is the marginal buyer. The board approved a US$300M repurchase on 2026-08-17 for up to 14.4 million shares — about 5% of shares outstanding as of 2026-08-14 — running 2026-08-24 through 2029-08-24. The shares rose 17.4% on the announcement (Simply Wall St, 2026-08-17). CEO Lewis Black's stated rationale was that the board does not believe the share price reflects the underlying value of the assets.
  • The balance sheet funds the next two phases without a raise. Cash stood at C$1.23B at 2026-06-30. Company materials name Phase II at Sangdong, the South Korean tungsten oxide facility, the Gentung project in Montana and the Panasqueira extension as parallel uses of convertible proceeds.
  • Capacity is a step function, not a grind. Phase I targets roughly 640,000 tonnes of annual throughput; Phase II is contemplated at 1.2 million tonnes, which company disclosure puts at 2027.
  • Sell-side is positioned above the tape. Investing.com's consensus across 8 analysts shows an average 12-month target of US$26.00, a range of US$19.99 to US$33.11, and a Strong Buy rating; DA Davidson raised its target to $33 from $25 on 2026-07-10.

Bear Case

  • The revenue line missed. Against US-dollar consensus, Q2 sales of US$31.053M came in under the US$35.038M estimate (Benzinga, 2026-08-11). Revenue grew nearly fivefold and still fell short — the ramp is running behind what the street modelled.
  • The headline EPS beat was almost entirely non-cash. Net income of C$181.8M included a C$173.1M aggregate net gain on derivative and warrant revaluation: a C$204.4M gain on embedded derivative liabilities, offset by a C$30.7M capped-call loss and a C$0.6M warrant loss. Strip it and the operating result is the C$17.6M adjusted EBITDA figure. The US$0.45 versus US$0.07 "beat" on the wires is a revaluation artifact.
  • The commodity did the work. APT at US$3,075/MTU is 6.8 times the year-ago average. A move back toward pre-2025 levels compresses realized pricing on any volume not locked under the GTP amendment.
  • Phase I is still in commissioning. The 2026-08-11 release describes Phase I as "in commissioning and ramp-up" — throughput began 2026-07-01, so no reported quarter yet contains a full, steady-state operating period.
  • The capital structure carries an equity claim. The convertible and capped-call complex that produced the C$173.1M revaluation swing is a live conversion overhang against the 14.4 million shares the buyback could retire.

Setup & Price Structure

The 2026-08-28 close was $18.04, 23.0% below the 52-week high of $23.42, with a three-month price change of -5.3%. RSI(14) at 69.3 alongside a price nearly a quarter under its high describes a sharp recent bounce inside a broader correction, not a breakout from a high base — the August advance off the 2026-08-11 print and the 2026-08-17 buyback pop has taken momentum to the edge of overbought while the structure above remains unrepaired. The $23.42 high is the level that dates the last time this narrative had full participation.

Crowding and positioning observables, stated as observables: retail-facing coverage clustered tightly on two August days (the 2026-08-11 print and the 2026-08-17 buyback headline, the latter appearing in a Benzinga "big stocks moving higher" roundup the same session); sell-side consensus of US$26.00 across 8 analysts sits well above the tape, so the gap is being closed by price, not by estimates; and the flow that is documented runs the other way from the usual late-cycle pattern — the company is authorized to retire stock rather than issue into strength, and no insider selling appears in the filings available for the window. The buyback opened 2026-08-24, four sessions before the reference close, so no repurchase execution has been disclosed yet.

One inference, labelled as such: a C$204.4M gain on embedded derivative liabilities is what a lower share price over the measurement period produces, since it shrinks the conversion option's value. That makes reported GAAP earnings inversely geared to the equity — strong quarters on the tape will tend to print weaker headline net income, and vice versa. Adjusted EBITDA is the line that tracks the business.

Catalyst Calendar (next 30 days)

  • No company-confirmed dated event falls inside 2026-08-29 to 2026-09-28. Q2 FY26 was reported 2026-08-11 for the quarter ended 2026-06-30; the next scheduled disclosure is the Q3 print.
  • 2026-08-24 through 2029-08-24 (running): the US$300M / 14.4 million-share repurchase window is open. The first disclosure of shares actually retired against that ceiling is the checkable item, and it has no fixed date.
  • ~2026-09-30 (est.): quarter-end European APT average. Q3's average against the Q2 US$3,075/MTU benchmark sets the revenue arithmetic the next print will show.
  • ~2026-11-12 (est.): Q3 FY26 results — the first reporting period fully inside Sangdong throughput operations, and the first clean read on whether Phase I is tracking toward roughly 640,000 tonnes annualized.
  • 2027 (company timeline): Phase II completion at Sangdong to approximately 1.2 million tonnes per annum, alongside the tungsten oxide facility.

Elapsed catalysts

  • Undated: results from the Sangdong molybdenum drilling program, last updated 2026-06-16. (passed 74d ago)

What Would Change Our Mind

The structural break is the August advance failing and the shares returning into the range that preceded the Q2 print and the buyback headline: a weekly close below $15.50 would do that, and would leave the 2026-08-17 authorization as a headline that bought four weeks rather than a floor.

The operating break is separate and arrives on the Q3 print (~2026-11-12, est.): a second consecutive quarter of revenue below consensus, or adjusted EBITDA failing to expand materially from C$17.6M despite a full quarter of Sangdong throughput, would say the ramp — not the tungsten price — is the binding constraint. On the commodity, European APT slipping back under US$2,000/MTU would remove roughly a third of the price tailwind that produced the 498% revenue line.

The narrative break would be mainstream critical-minerals coverage arriving without a widening bid — that is, further multi-outlet attention while the shares fail to reclaim the $23.42 high. That combination would mark the story as saturated rather than maturing.

Correlation Notes

  • Trades with the non-China critical-minerals complex and with China export-policy headlines; any easing of Chinese tungsten export licensing compresses the scarcity premium embedded in a US$3,075/MTU APT print.
  • Small-cap risk appetite is a live factor — the Russell 2000 was setting record highs on 2026-08-14, three days after the Q2 print, so August strength here overlaps with an index-level bid rather than being cleanly idiosyncratic.
  • Reporting is in Canadian dollars while the commodity, the offtake and US consensus estimates are in US dollars, so CAD/USD moves the headline growth rates without touching the business.
  • The shares are listed on Nasdaq as ALM, on the TSX and on the ASX, so price discovery is split across three sessions and the US tape inherits overnight moves.
  • Q2 GAAP earnings are dominated by derivative revaluation, meaning reported net income correlates with the share price itself rather than with tungsten volumes.

Notes

  • Reports in Canadian dollars; US wires convert, so C$43.0M Q2 revenue prints as ~US$31.1M against USD consensus — check the currency before comparing to estimates.
  • Triple-listed: Nasdaq (ALM), TSX (AII). Price discovery is split across three time zones and the US session inherits overnight moves.
  • Embedded-derivative and capped-call liabilities from the convertible structure make GAAP net income swing on non-cash revaluation (C$173.1M net gain in Q2 FY26).
  • The US$300M / 14.4M-share program approved 2026-08-17 is an authorization running to 2029-08-24, not a commitment; actual repurchases are disclosed after the fact.

Related · shared themes

ATEX

Anterix Inc.

Fourth consecutive up-close, $94.67 on 2026-08-27, holds the $88.20 shelf reclaimed 2026-08-21, but nothing company-dated backs it: no 8-K since 2026-08-11, no announced spectrum sale since 2026-04-21, and a third insider sale on 2026-08-25 (CRO exercised 40,000 options at $34.72, sold same day). The saturated conversion story runs on undated deal flow into the 2026-09-21 buyback expiry.

MEDIUM

DAVE

Dave Inc.

The 2026-08-26 reclaim held: a 2026-08-27 close of $374.01 is a second session above the $358.59 50-day and the $359.85 recovery high, still on no company disclosure since the 2026-08-05 print and no rating action since Piper Sandler's $390 initiation on 2026-08-17. RSI(14) at 73.1 arrives with nothing company-dated before Q3 results around 2026-11-04, leaving a maturing narrative carried by a 24.65%-of-float short base.

MEDIUM

MRCY

Mercury Systems Inc

Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

See also · stocks to watch